Medipharm Labs Corp
TSX:LABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Blacksky Technology Inc
NYSE:BKSY
|
US |
|
Yellow Corp
OTC:YELLQ
|
US |
|
Weihai Guangwei Composites Co Ltd
SZSE:300699
|
CN |
|
Lojas Quero-Quero SA
BOVESPA:LJQQ3
|
BR |
|
Wallstreet online AG
XETRA:WSO1
|
DE |
Medipharm Labs Corp
Non-Reccuring Items
Medipharm Labs Corp
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medipharm Labs Corp
TSX:LABS
|
Non-Reccuring Items
CA$1.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Non-Reccuring Items
-$210m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Non-Reccuring Items
-CA$32.7m
|
CAGR 3-Years
75%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Non-Reccuring Items
-$2.8m
|
CAGR 3-Years
66%
|
CAGR 5-Years
44%
|
CAGR 10-Years
-9%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Non-Reccuring Items
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Non-Reccuring Items
-CA$7.5m
|
CAGR 3-Years
30%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Medipharm Labs Corp
Glance View
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.
See Also
What is Medipharm Labs Corp's Non-Reccuring Items?
Non-Reccuring Items
1.8m
CAD
Based on the financial report for Dec 31, 2025, Medipharm Labs Corp's Non-Reccuring Items amounts to 1.8m CAD.
What is Medipharm Labs Corp's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
10%
Over the last year, the Non-Reccuring Items growth was 133%.
